NCT00357747 2023-08-04
AEG35156 and Docetaxel in Treating Patients With Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
Clinical Trials
14 trialsNCT00372736 2023-08-04
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00504296 2023-08-04
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00003891 2020-04-09
Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00003890 2020-04-06
MG98 in Treating Patients With Advanced Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00387504 2013-09-12
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
California Cancer Consortium
Phase 1 Completed
NCT00004886 2012-09-24
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00045019 2012-08-27
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
European Organisation for Research and Treatment of Cancer - EORTC
Completed
NCT00006354 2012-07-24
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00005061 2012-07-18
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00006477 2012-07-18
Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00003976 2012-07-11
E7070 in Treating Patients With Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00003981 2012-07-11
E7070 in Treating Patients With Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00003028 2012-07-02
MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed